
Xavier Forns
Hepatology Services HepatologistFeatured publications
-
Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries
Authors:Reference: Journal Of Hepatology 2023. -
Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)
Authors:Reference: Gastroenterology 2022. -
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Authors:Reference: Journal Of Hepatology 2021. -
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Authors:Reference: Journal Of Hepatology 2020. -
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions in the near future
Authors:Reference: Journal Of Hepatology 2020. -
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: relevance of non-characterized nodules
Authors:Reference: Journal Of Hepatology 2019. -
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.
Authors:Reference: Journal Of Viral Hepatitis 2018. -
Shorter HBIG administration is not associated to HBV recurrence when receiving combined prophylaxis after liver transplantation.
Authors:Reference: Liver International 2018. -
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection.
Authors:Reference: Hepatology 2018. -
Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients.
Authors:Reference: Journal Of Hepatology 2018.
Featured Projects
-
Estudio de la disfunción de la respuesta inmune adaptativa periférica e intrahepática en las diferentes fases de la hepatitis crónica por el virus de la hepatitis B
Principal investigator: Xavier Forns BernhardtFunder: Instituto de Salud Carlos IIICode: PI18/00079Duration: 01/01/2019 - 01/01/2022 -
Evaluación prospectiva de un modelo externalizado de consulta especializada con intervención educacional para reducir la reinfección por el virus de la hepatitis C en un centro de reducción de daños
Principal investigator: Xavier Forns BernhardtCode: 2020I018Duration: 01/01/2021 - 31/12/2022 -
TherVacB: A therapeutic vaccine to cure hepatitis B
Principal investigator: Xavier Forns BernhardtCode: 848223Duration: 01/01/2020 - 31/12/2024 -
Defining the best strategy for global HCV screening, linkage-to-care, education and prevention in PWID population and validation of a new diagnostic dried blood spot test
Principal investigator: Sabela Lens GarcíaCode: IN-ES-987-5349Duration: 02/05/2018 - 31/03/2022